Pacific Biosciences Of California | PACB - Market Capitalization


Pacific Biosciences Of California reported $527.9M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 39.08B 6.43B Jun/2026
Bruker USD 9.68B 181M Nov/2026
Danaher USD 157.81B 18.96B Sep/2026
General Electric Aerospace USD 324.02B 65.91B Sep/2026
Illumina USD 37.12B 3.64B Nov/2026
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quidel USD 942M 192M Nov/2026
Revvity USD 19.52B 2.61B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Standard Biotools USD 227M 95M Nov/2026
Thermo Fisher Scientific USD 249.58B 58.93B Sep/2026
Waters USD 27.52B 14.26B Nov/2026